Kristen Hassmiller Lich

Kristen Hassmiller Lich

Auto-generated profile, based on publicly available information

Kristen Hassmiller Lich

University of North Carolina at Chapel Hill

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2012 in Prevention Science
Verified
Journal Article
Closed access
PDF file
KLKristen Hassmiller Lich
Kristen Hassmiller Lich
EGElizabeth M. Ginexi
Elizabeth M. Ginexi
NONathaniel D. Osgood
Nathaniel D. Osgood
PMPatricia L Mabry
Patricia L Mabry

1 August 2017 in Preventive Medicine
Verified
Journal Article
Closed access
MDMelinda M. Davis
Melinda M. Davis
SRStephanie Renfro
Stephanie Renfro
RPRobyn Pham
Robyn Pham
KLKristen Hassmiller Lich
Kristen Hassmiller Lich
JSJackilen Shannon
Jackilen Shannon
SWStephanie B Wheeler
Stephanie B Wheeler

23 May 2014 in International Journal of Behavioral Medicine
Verified
Journal Article
Closed access
PDF file
JBJessica G. Burke
Jessica G. Burke
KLKristen Hassmiller Lich
Kristen Hassmiller Lich
JNJennifer Watling Neal
Jennifer Watling Neal
HMHelen I. Meissner
Helen I. Meissner
MYMichael Yonas
Michael Yonas
PMPatricia L Mabry
Patricia L Mabry

1 February 2017 in Evaluation and Program Planning
Verified
Journal Article
Closed access
KLKristen Hassmiller Lich
Kristen Hassmiller Lich
JUJennifer Brown Urban
Jennifer Brown Urban
LFLeah Frerichs
Leah Frerichs
GDGaurav Dave
Gaurav Dave

28 April 2020 in BMC Public Health
Verified
Journal Article
Open access
PDF file
CAChris B Agala
Chris B Agala
BFBruce J. Fried
Bruce J. Fried
JTJames C. Thomas
James C. Thomas
HRHeidi W. Reynolds
Heidi W. Reynolds
KLKristen Hassmiller Lich
Kristen Hassmiller Lich
JMJoseph P. Morrissey
Joseph P. Morrissey
Background: Adherence to antiretroviral therapy is critical to the achievement of the third target of the UNAIDS Fast-Track Initiative goals of 2020–2030. Reliable, valid and accurate measurement of adherence are important for correct assessment of adherence and in predicting the efficacy of ART. The Simplified Medication Adherence Questionnaire is a six-item scale which assesses the perception of persons living with HIV about their adherence to ART. Despite recent widespread use, its measurement properties have yet to be carefully documented beyond the original study in Spain. The objective of this paper was to conduct internal consistency reliability, concurrent validity and measurement invariance tests for the SMAQ. Methods: HIV-positive women who were receiving ART services from 51 service providers in two sub-cities of Addis Ababa, Ethiopia completed the SMAQ in a HIV treatment referral network study between 2011 and 2012. Two cross-sections of 402 and 524 female patients of reproductive age, respectively, from the two sub-cities were randomly selected and interviewed at baseline and follow-up. We used Cronbach’s coefficient alpha (α) to assess internal consistency reliability, Pearson product-moment correlation (r) to assess concurrent validity and multiple-group confirmatory factor analysis to analyze factorial structure and measurement invariance of the SMAQ. Results: All participants were female with a mean age of 33; median: 34 years; range 18–45 years. Cronbach’s alphas for the six items of the SMAQ were 0.66, 0.68, 0.75 and 0.75 for T1 control, T1 intervention, T2 control, and T2 intervention groups, respectively. Pearson correlation coefficients were 0.78, 0.49, 0.52, 0.48, 0.76 and 0.80 for items 1 to 6, respectively, between T1 compared to T2. We found invariance for factor loadings, observed item intercepts and factor variances, also known as strong measurement invariance, when we compared latent adherence levels between and across patient-groups. Conclusions: Our results show that the six-item SMAQ scale has adequate reliability and validity indices for this sample, in addition to being invariant across comparison groups. The findings of this study strengthen the evidence in support of the increasing use of SMAQ by interventionists and researchers to examine, pool and compare adherence scores across groups and time periods.

30 November 2014 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
MPMichael P Pignone
Michael P Pignone
TCTrisha M Crutchfield
Trisha M Crutchfield
PBPaul Brown
Paul Brown
SHSarah T Hawley
Sarah T Hawley
JLJane L Laping
Jane L Laping
SWStephanie B Wheeler
Stephanie B Wheeler
Screening for colorectal cancer (CRC) is suboptimal, particularly for vulnerable populations. Effective intervention programs are needed to increase screening rates. We used a discrete choice experiment (DCE) to learn about how vulnerable individuals in North Carolina value different aspects of CRC screening programs. We enrolled English-speaking adults ages 50–75 at average risk of CRC from rural North Carolina communities with low rates of CRC screening, targeting those with public or no insurance and low incomes. Participants received basic information about CRC screening and potential program features, then completed a 16 task DCE and survey questions that examined preferences for four attributes of screening programs: testing options available; travel time required; money paid for screening or rewards for completing screening; and the portion of the cost of follow-up care paid out of pocket. We used Hierarchical Bayesian methods to calculate individual-level utilities for the 4 attributes’ levels and individual-level attribute importance scores. For each individual, the attribute with the highest importance score was considered the most important attribute. Individual utilities were then aggregated to produce mean utilities for each attribute. We also compared DCE-based results with those from direct questions in a post-DCE survey. We enrolled 150 adults. Mean age was 57.8 (range 50–74); 55% were women; 76% White and 19% African-American; 87% annual household income under $30,000; and 51% were uninsured. Individuals preferred shorter travel; rewards or small copayments compared with large copayments; programs that included stool testing as an option; and greater coverage of follow-up costs. Follow-up cost coverage was most frequently found to be the most important attribute from the DCE (47%); followed by test reward/copayment (33%). From the survey, proportion of follow-up costs paid was most frequently cited as most important (42% of participants), followed by testing options (32%). There was moderate agreement (45%) in attribute importance between the DCE and the single question in the post-DCE survey. Screening test copayments and follow-up care coverage costs are important program characteristics in this vulnerable, rural population.